Business Wire

Digital Storytelling Platform ALEXANDER Launches with All-Star Cast

Share

Alexander is the digital home of original non-fiction stories from around the world. Bringing together some of the world’s most respected creative talent, Alexander’s feature stories are commissioned from acclaimed global authors and journalists and give unique access to fascinating places, cultures and people.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201124005565/en/

Using the Alexander mobile app, every original feature is presented in multiple storytelling dimensions—a commissioned written story, an audio performance and a super short film. The crafted film introduces the setting, teases the subject and sets the mood. Audiences then transition into the full story and can read, listen or move seamlessly via The Toggle, a proprietary text-to-audio functionality, between the written word and the audio performance. The convergence creates an immersive storytelling experience that meets the high expectations of discerning audiences everywhere.

Conceived and created by veteran film producer Cameron Lamb, Alexander harnesses the talents of an all-star cast of award-winning authors, A-list actors and celebrated filmmakers.

Commissioned writers include National Book Award winner Colum McCann, National Book Critics Circle Award winner Xiaolu Guo, Two-time Booker Prize-nominated Chigozie Obioma, theoretical physicist Carlo Rovelli and National Book Critics Circle Award finalist Valeria Luiselli.

Audio performances include Academy Award nominees Helena Bonham Carter and Richard E. Grant, BAFTA and Golden Globe winner Bill Nighy, BAFTA winners Vanesa Kirby and David Tennant and SAG nominated Dan Stevens along with Daisy Edgar-Jones, ope Dìrísù and Nathalie Emmanuel among others.

Super short films come from directors including Charlotte Wales and Derek Zheng, and star the likes of Emma Corrin (debuting as Princess Diana in Netflix’s The Crown, November 2020).

“Alexander is for a global audience starved of those intimate, transporting stories that give real access to international and unexplored subjects and places,” said Alexander founder Cameron Lamb. “I wanted to create something different. To bring together three familiar mediums, entwined, working cohesively together, to deliver an immersive world. Alexander commissions brilliant writers who can find a remarkable story in a place or topic and make it feel immediate and familiar. The incredible group of actors and filmmakers we’ve brought together elevate each of these story experiences, capturing audiences from the moment they drop into the app. It’s a unique experience.”

Dugong
By J.M. Ledgard with audio performance by David Tennant and film by Russ Murphy. Traveling from the remote islands of the Torres Strait to the waters of the Arabian Gulf in search of the elusive dugong, Ledgard looks to both past and future in the race to preserve a species in the Anthropocene Age.

Killing in the Year of the Pig
By Xiaolu Guo with audio performance by Guo and film by Derek Zheng. Guo revisits the China of her childhood to unfold the story of two mass-murdering brothers and their months-long killing spree that transfixes a nation.

When the Risen Dust Settles
By Chigozie Obioma with audio performance by Ṣope Dìrísù and film by Zacker Canaperi and Drea Cooper. Nigeria’s Caritas University is ruled by the arbitrary discipline of a charismatic Catholic priest. Students are kept in dormitories without sanitation, barred from outside contact, beaten for misbehavior, and summarily expelled. When Obioma's curiosity makes him question the institution and its founder, he becomes the main target for the culture of control.

Seasick
By Jonathan Freedland with audio performance by Richard E. Grant and film by the McGloughlin Brothers. What happens when culture loses its memory and truth can’t be trusted? Jonathan Freedland, one of the world’s top political reporters, meets the people around the globe who are fighting against tech-age misinformation, Holocaust denial and the War on Facts.

In addition to new original features, Alexander also includes a curated library of historical non-fiction stories that have stood the test of time, freshly packaged in the Alexander experience.

The Alexander app will be available by subscription on iOS and downloadable on the App Store from November 24, 2020. Monthly subscription rates begin at $3.99/£3.99 following a 14-day complimentary trial. The app will be available for Android in early 2021.

Alexander App Download - https://apps.apple.com/us/app/alexander/id1529631224

--------------

About Alexander

Alexander brings global stories into accessible, captivating immediacy with high-quality original non-fiction storytelling in an audience-friendly technology experience. Every two weeks, Alexander releases an original English-language feature in its subscription application. Created by the world’s best storytellers, each feature comprises a commissioned written narrative by an award-winning author complemented and enhanced by an audio performance by A-list acting talent and a super short film of the story as interpreted by a visionary filmmaker.

For more information, visit www.alxr.com

Follow Alexander on Instagram or Twitter @alxrfeatures

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For EU media requests, please contact:
Josh Stanbury | josh@sjspr.co | +44 (0)7590 720870

For US media requests, please contact:
Charlie Windisch-Graetz | Charlie@c4global.com | +1-310-801-6910

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye